NASDAQ
Intra-Cellular Therapies, Inc. (ITCI) has a revenue compound annual growth rate of 545.80% over 5 years and 102.85% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.